Agenus (AGEN) Retained Earnings (2010 - 2026)
Agenus (AGEN) posted quarterly Retained Earnings of -$2.1 billion for Q1 2026, up 2.57% year-over-year from -$2.1 billion in Q1 2025, and down 212.13% quarter-over-quarter from $1.9 billion in Q4 2025.
Agenus (AGEN) Retained Earnings (2010 - 2026) Analysis & Trends
Agenus' Retained Earnings history runs 17 years deep, the most recent figure standing at -$2.1 billion for Q1 2026.
- In Q1 2026, Retained Earnings rose 2.57% year-over-year to -$2.1 billion; the TTM figure through Mar 2026 stood at -$2.1 billion (up 2.57% YoY), while the FY2025 annual figure was $1.9 billion, up 136848.21% from the prior year.
- Retained Earnings for Q1 2026 stood at -$2.1 billion, down from $1.9 billion in the prior quarter.
- The five-year high for Retained Earnings was $1.9 billion in Q4 2025, with the low at -$2.2 billion in Q1 2025.
- The 5-year median for Retained Earnings is -$1.5 billion (2022), against an average of -$579.6 million.
- The sharpest annual moves came in 2022 and 2023: Retained Earnings plunged 149600.6% in 2022, then soared 275906.21% in 2023.
- Agenus' Retained Earnings stood at -$1.7 billion in 2022, then fell by 14.37% to -$2.0 billion in 2023, then jumped by 99.93% to -$1.4 million in 2024, then surged by 136848.21% to $1.9 billion in 2025, then sank by 212.13% to -$2.1 billion in 2026.
- Business Quant data shows AGEN's Retained Earnings at -$2.1 billion in Q1 2026, $1.9 billion in Q4 2025, and $1.9 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Agenus | 311.95 Mn | 286.43 Mn | 34.52 Mn | -2.14 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.14 Bn |
| Mar 31, 2026 | -2.14 Bn |
| Dec 31, 2025 | 1.91 Bn |
| Sep 30, 2025 | 1.90 Bn |
| Jun 30, 2025 | -1.50 Mn |
| Mar 31, 2025 | -2.20 Bn |
| Dec 31, 2024 | -1.40 Mn |
| Sep 30, 2024 | -2.14 Bn |
| Jun 30, 2024 | 1.83 Bn |
| Mar 31, 2024 | -2.00 Bn |
| Dec 31, 2023 | -1.96 Bn |
| Sep 30, 2023 | 1.78 Bn |
| Jun 30, 2023 | -1.85 Bn |
| Mar 31, 2023 | -1.78 Bn |
| Dec 31, 2022 | -1.71 Bn |
| Sep 30, 2022 | 644,000.00 |
| Jun 30, 2022 | 2.15 Mn |
| Mar 31, 2022 | -1.50 Bn |
| Dec 31, 2021 | 1.49 Mn |
| Sep 30, 2021 | -1.40 Bn |